Peter G. Smith | Academic Influence

Peter G. Smith's AcademicInfluence.com Rankings

Peter G. Smith

Computer Science

#8737

World Rank

#9187

Historical Rank

Machine Learning

#3656

World Rank

#3702

Historical Rank

Artificial Intelligence

#3967

World Rank

#4025

Historical Rank

Database

#5738

World Rank

#5954

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Peter G. Smith's Degrees

PhD Computer Science Stanford University
Masters Artificial Intelligence University of California, Berkeley

Similar Degrees You Can Earn

Why Is Peter G. Smith Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Peter G. Smith's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. (2014) (686)
Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study (1978) (559)
Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea. (2016) (467)
A New Method for the Detection of Peptides and Similar Compounds on Paper Chromatograms (1952) (426)
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression (2022) (408)
Evaluation of diagnostic tests for infectious diseases: general principles (2006) (288)
Characteristics of women with dysplasia or carcinoma in situ of the cervix uteri. (1980) (267)
MMR vaccination and pervasive developmental disorders: a case-control study (2004) (259)
Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran (1998) (245)
Predicting the CJD epidemic in humans (1997) (209)
Lymphocyte Survival in Men treated with X-rays for Ankylosing Spondylitis (1967) (205)
Human Challenge Studies to Accelerate Coronavirus Vaccine Licensure (2020) (193)
First generation leishmaniasis vaccines: a review of field efficacy trials. (2008) (192)
Evaluation of diagnostic tests for infectious diseases: general principles (2006) (190)
The natural history of HIV-1 and HIV-2 infections in adults in Africa: a literature review. (2004) (165)
Validation of the diagnosis of autism in general practitioner records (2004) (159)
WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23–24 March 2015 (2015) (154)
Human population cytogenetics. (1969) (150)
Bovine spongiform encephalopathy (BSE) and its epidemiology. (2003) (136)
Variability of infectious aerosols produced during coughing by patients with pulmonary tuberculosis. (2012) (130)
Predictability of the UK Variant Creutzfeldt-Jakob Disease Epidemic (2001) (125)
Geographical Variation in the Response of Visceral Leishmaniasis to Paromomycin in East Africa: A Multicentre, Open-Label, Randomized Trial (2010) (123)
Risk factors for variant Creutzfeldt–Jakob disease: A case–control study (2006) (122)
Evaluation of diagnostic tests for infectious diseases: general principles. (2010) (101)
Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine. (2019) (97)
Effectiveness of the Standard WHO Recommended Retreatment Regimen (Category II) for Tuberculosis in Kampala, Uganda: A Prospective Cohort Study (2011) (94)
A guide for diagnostic evaluations (2006) (91)
Obstacles to conducting epidemiological research in the UK general population (2004) (90)
Setting research priorities to improve global newborn health and prevent stillbirths by 2025 (2015) (83)
The Use of Ebola Convalescent Plasma to Treat Ebola Virus Disease in Resource-Constrained Settings: A Perspective From the Field (2015) (82)
WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27–28 April 2016 (2016) (81)
Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization (2021) (79)
Measurement of malaria vaccine efficacy in phase III trials: report of a WHO consultation. (2007) (79)
Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda. (2008) (76)
Hepatocellular carcinoma in primary haemochromatosis in the absence of cirrhosis. (1988) (69)
Safety and Efficacy of Single Dose versus Multiple Doses of AmBisome® for Treatment of Visceral Leishmaniasis in Eastern Africa: A Randomised Trial (2014) (69)
Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls (2017) (68)
Chapter 28: Studies to assess the long-term efficacy and effectiveness of HPV vaccination in developed and developing countries. (2006) (68)
Editorial: ‘Non‐specific effects of vaccines’– an important analytical insight, and call for a workshop (2006) (61)
Creating a Framework for Conducting Randomized Clinical Trials during Disease Outbreaks. (2020) (59)
A guide for diagnostic evaluations (2006) (57)
Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS (2009) (57)
Observational study to estimate the changes in the effectiveness of bacillus Calmette-Guérin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK. (2017) (54)
Risk factors for sporadic Creutzfeldt–Jakob disease (2008) (53)
Preparation for Phase III HIV vaccine efficacy trials: methods for the determination of HIV incidence (1994) (52)
Tamoxifen-associated hepatocellular damage and agranulocytosis (1992) (52)
Disease clustering: a generalization of Knox's approach to the detection of space-time interactions. (1968) (51)
Low-cost rapid detection of rifampicin resistant tuberculosis using bacteriophage in Kampala, Uganda (2007) (51)
Concepts of herd protection and immunity (2010) (50)
Secretion of Catecholamines in Malignant Phaeochromocytoma (1964) (50)
Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group (2020) (50)
Antiretroviral treatment in resource‐poor settings: public health research priorities (2005) (47)
Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines. (2018) (47)
Live-attenuated tetravalent dengue vaccines: The needs and challenges of post-licensure evaluation of vaccine safety and effectiveness. (2017) (46)
Report from the World Health Organization's Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 7–9th Sep 2015☆ (2016) (45)
Placebo use in vaccine trials: Recommendations of a WHO expert panel (2014) (45)
Long-term safety assessment of live attenuated tetravalent dengue vaccines: Deliberations from a WHO technical consultation (2013) (44)
Chronic liver disease associated with childhood ulcerative colitis (1974) (44)
Practical and theoretical implications of fetal-maternal lymphocyte transfer. (1969) (44)
The duration of protection of school-aged BCG vaccination in England: a population-based case-control study. (2018) (42)
Rate of first recorded diagnosis of autism and other pervasive developmental disorders in United Kingdom general practice, 1988 to 2001 (2004) (42)
A guide for diagnostic evaluations. (2010) (41)
Considerations for using ETEC and Shigella disease burden estimates to guide vaccine development strategy (2019) (41)
Prospective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim® (dihydroartemisinin/piperaquine), in public health facilities in Burkina Faso, Mozambique, Ghana, and Tanzania (2015) (41)
MALVAC 2008: Measures of efficacy of malaria vaccines in phase 2b and phase 3 trials--scientific, regulatory and public health perspectives. (2009) (41)
The Incubation Period of Kuru (2002) (41)
Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristics. (2018) (40)
CONTACTS BETWEEN YOUNG PATIENTS WITH HODGKIN'S DISEASE A Case-Control Study (1977) (40)
A case-control study of autism and mumps-measles-rubella vaccination using the general practice research database: design and methodology (2001) (39)
The epidemics of bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: current status and future prospects. (2003) (39)
Primary gastric lymphoma in clinical practice 1973-1992. (1995) (39)
Socioeconomic determinants of schistosomiasis in an urban area in the Northeast of Brazil. (2003) (39)
Reaching Millennium Development Goal 4 – The Gambia (2011) (38)
Leukemia and other cancers following radiation treatment of pelvic disease (1977) (38)
TREATMENT OF SMALL-CELL CARCINOMA OF BRONCHUS (1975) (37)
Rickets and amino-aciduria. (1952) (37)
WHO consultation on ETEC and Shigella burden of disease, Geneva, 6-7th April 2017: Meeting report. (2018) (37)
Cancers among users of preparations containing vitamin A. A case‐control investigation (1978) (37)
Cancer Incidence in Five Continents. Comparison between registries: age-standardized rates. (1992) (35)
A Cluster-Randomised Trial to Compare Home-Based with Health Facility-Based Antiretroviral Treatment in Uganda: Study Design and Baseline Findings (2007) (35)
Effects of misclassification of causes of death on the power of a trial to assess the efficacy of a pneumococcal conjugate vaccine in The Gambia. (2003) (35)
Case-control vaccine effectiveness studies: Data collection, analysis and reporting results (2017) (33)
Case-control approach to examine diseases for evidence of contagion, including diseases with long latent periods. (1974) (33)
Carcinoid tumour of the common bile duct--a novel complication of von Hippel-Lindau syndrome. (1990) (33)
Epidemiological studies of the ‘non‐specific effects’ of vaccines: I – data collection in observational studies (2009) (33)
Does respiratory syncytial virus lower respiratory illness in early life cause recurrent wheeze of early childhood and asthma? Critical review of the evidence and guidance for future studies from a World Health Organization-sponsored meeting (2020) (33)
Vaccination and world health (1995) (31)
Choices in vaccine trial design in epidemics of emerging infections (2018) (31)
The role of dose rate, irradiation technique, and LET in determining radiosensitivities at low oxygen concentrations. (1967) (31)
Treatment Outcomes of New Tuberculosis Patients Hospitalized in Kampala, Uganda: A Prospective Cohort Study (2014) (29)
The impact of childhood vaccines on bacterial carriage in the nasopharynx: a longitudinal study (2015) (29)
The role of immune correlates of protection on the pathway to licensure, policy decision and use of group B Streptococcus vaccines for maternal immunization: considerations from World Health Organization consultations (2019) (28)
CRYPTOCOCCOSIS OF THE HEART (1965) (26)
Floor of Mouth Cancer: Patient Selection and Treatment Results (1983) (25)
Generalisations of two tests for the detection of household aggregation of disease. (1976) (24)
Chromosome Damage Induced by Radiation (1968) (22)
Early and late effects of accelerated charged particles on normal tissues. (1977) (20)
The predictability of the epidemic of variant Creutzfeldt-Jakob disease by back-calculation methods (2003) (20)
Factory populations exposed to crocidolite asbestos - a continuing survey. (1976) (20)
Vaccine-attributable severe dengue in the Philippines (2019) (20)
Tonsillectomy and Hodgkin's disease. (1973) (20)
Leveraging the Global Influenza Surveillance and Response System for global respiratory syncytial virus surveillance—opportunities and challenges (2019) (19)
Current assessment of “case clustering” of lymphomas and leukemias (1978) (18)
Clustering of cases of Hodgkin's disease and leukemia (1974) (18)
Sustainable development of a GCP-compliant clinical trials platform in Africa: the Malaria Clinical Trials Alliance perspective (2010) (18)
Comparative efficacy of low-dose versus standard-dose azithromycin for patients with yaws: a randomised non-inferiority trial in Ghana and Papua New Guinea (2018) (18)
Estimating the proportion of vaccine-induced hospitalized dengue cases among Dengvaxia vaccinees in the Philippines (2019) (17)
Design and analysis considerations in the Ebola_Tx trial evaluating convalescent plasma in the treatment of Ebola virus disease in Guinea during the 2014–2015 outbreak (2016) (17)
Approaches to use the WHO respiratory syncytial virus surveillance platform to estimate disease burden (2019) (17)
Comparison of rapid tests for detection of rifampicin-resistant Mycobacterium tuberculosis in Kampala, Uganda (2009) (17)
Total metadrenaline excretion in patients treated with alpha-methyldopa. (1963) (17)
Sensitivity and negative predictive value for a rapid dengue test. (2019) (17)
Single-dose liposomal amphotericin B (AmBisome®) for the treatment of Visceral Leishmaniasis in East Africa: study protocol for a randomized controlled trial (2011) (16)
Evaluation of adverse effects of vaccines: the case-control approach. (2002) (16)
URINARY EXCRETION OF A.I.C. IN VITAMIN-B12 AND FOLIC-ACID DEFICIENCIES (1964) (16)
Treatment of early Hodgkin's disease. (1967) (15)
Non-specific effects of BCG? (2012) (15)
Effects of topically-applied olive oil on the response of hamster skin to single or multiple doses of 230kV X-rays. (1977) (14)
Guidance on the evaluation of Plasmodium vivax vaccines in populations exposed to natural infection. (2009) (14)
A Radio Method of determining the Velocity of a Shock Wave (1957) (14)
Cellular response of a rat brain tumour to a therapeutic neon ion beam. (1977) (14)
The European and developing countries clinical trails partnership. (2004) (14)
Annals of Clinical Microbiology and Antimicrobials (2017) (14)
Clinical trials to estimate the efficacy of preventive interventions against malaria in paediatric populations: a methodological review (2009) (13)
Multiple cases of Burkitt's lymphoma and other neoplasms in families in the north mara district of Tanzania (1980) (12)
Selection and quantification of infection endpoints for trials of vaccines against intestinal helminths (2011) (12)
The geographical distribution of variant Creutzfeldt-Jakob disease cases in the UK: what can we learn from it? (2003) (11)
Folate deficiency and the pill. (1971) (11)
Integrating health services for HIV infection, diabetes and hypertension in sub-Saharan Africa: a cohort study (2021) (10)
Technical aspects of intraoperative monitoring of lower cranial nerve function. (1995) (10)
The serodiagnosis of leprosy. (1992) (10)
Clustering in Hodgkin's disease. (1973) (9)
Intestinal absorption of coenzyme B12 in the normal and fluoroacetate-poisoned rat. (1962) (9)
Case-control Studies of Common Childhood Diseases: The Example of Diarrhoea (1995) (9)
Response to Cioffi. (2020) (8)
Global diarrhoea-associated mortality estimates and models in children: Recommendations for dataset and study selection. (2021) (8)
CARCINOMA OF PENIS AND CERVIX (1980) (8)
WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants – Key considerations for global use (2022) (8)
INCIDENCE OF CHILDHOOD LEUKÆMIA (1974) (8)
Meeting report: WHO consultation on accelerating Lassa fever vaccine development in endemic countries, Dakar, 10-11 September 2019. (2020) (8)
HORMONE REPLACEMENT THERAPY AND ENDOMETRIAL CARCINOMA (1977) (7)
Foresight. Infectious Diseases: preparing for the future: Executive Summary (2006) (7)
A guide for diagnostic evaluations. (2006) (7)
Ethical issues in intervention studies on the prevention and management of diabetes and hypertension in sub-Saharan Africa (2020) (6)
Evaluation of diagnostic tests for infectious diseases: general principles. (2008) (6)
Is the New Variant of Creutzfeldt-Jakob Disease from Mad Cows? (1996) (6)
Protection by BCG against tuberculosis : a systematic review of randomised controlled trials (2018) (6)
Clinical characteristics, predictors, and performance of case definition—Interim results from the WHO global respiratory syncytial virus surveillance pilot (2020) (6)
Scale-up of antiretroviral therapy in sub-Saharan Africa: priorities for public health research. (2007) (5)
Embargo on publication of scientific papers by Iranian authors (2012) (5)
Randomised trial of two-drug and four-drug maintenance chemotherapy in advanced or recurrent Hodgkin's disease. Medical Research Council's working party on lymphomas. (1979) (5)
Pregnancy planning in Hawaii. (1975) (5)
Editorial: Scale‐up of antiretroviral therapy in sub‐Saharan Africa – priorities for public health research (2007) (5)
Blastomycosis of the epididymis and prostate; a case report. (1950) (5)
Novel vaccine safety issues and areas that would benefit from further research (2021) (4)
Drug misuse, tobacco smoking, alcohol and other social determinants of tuberculosis in UK-born adults in England: a community-based case-control study (2020) (4)
The 1957 MRC report on leukaemia and aplastic anaemia in patients irradiated for ankylosing spondylitis (2007) (4)
Revised estimates of global leprosy numbers. (1992) (4)
Assessing the impact of disease. (1982) (4)
A comparison of two methods for calculating expected mortality. (1984) (3)
Observation of Far-Infra-Red Radiation from Shock Waves (1961) (3)
A vaccine against malaria: a substantial step forward (2009) (3)
Proceedings: Liver damage in patients taking methyldopa. (1974) (3)
EVIDENCE FOR THE CELLULAR BASIS OF INTESTINAL DEATH IN MICE, FROM AN ANALYSIS OF DOSE-EFFECT RELATIONSHIPS MODIFIED BY QUALITY OF RADIATION, DOSE RATE, FRACTIONATION AND ANOXIA. (1968) (3)
Malaria vaccine: 3 or 6 months protection? [letter] (2005) (3)
Daan Mulder Memorial Symposium – Introduction (2000) (2)
Hepatitis B control in African countries (1991) (2)
Panel V: Distant disease (1992) (2)
TYROSINE METABOLISM IN HYPOXIA (1967) (2)
Integrating HIV, diabetes and hypertension services in Africa: study protocol for a cluster randomised trial in Tanzania and Uganda (2021) (2)
Radio Observations of Hypersonic Shock Waves (1958) (2)
Response to Dawson et al. (2020) (2)
A study of burns injuries in Uganda. (1972) (2)
Does cotrimoxazole taken by HIV-infected individuals reduce mortality among HIV-uninfected family members? Data may not support conclusion. (2006) (1)
Primary carcinoma in bladder diverticula. (1950) (1)
Controlling diabetes and hypertension in sub-Saharan Africa: lessons from HIV programmes (2021) (1)
Parasympathetic Prejunctional Inhibition of Cardiac Sympathetic Nerves is Reduced in a Rodent Model of Heart Failure. (2009) (1)
The Role of Information Systems in Clinical and Translational Research (Frontiers: The NIH Clinical and Translational Science Award Driving Information Systems) (2012) (1)
ADRENALINE-SECRETING PHÆOCHROMOCYTOMATA (1962) (1)
Liver-fluke infection in man. (1963) (1)
Conference report: Vaccination and World Health: 18–20 April 1994, London School of Hygiene and Tropical Medicine, London, UK (1994) (1)
Embryological implications of the male vagina. (1971) (1)
Epidemiology of Burkitt's lymphoma. (1972) (1)
Let's not confuse the issues. (1986) (0)
Letter: Hodgkin's disease mortality among physicians. (1964) (0)
SEROPOSITIVITY TO HIV-1 AND HIV-2 (1987) (0)
Ethics review of COVID-19 human challenge studies: A joint HRA/WHO workshop (2022) (0)
'Relapse' of chronic active hepatitis--not always what it seems. (1996) (0)
Hepatocellular carcinoma inprimary haemochromatosis intheabsence ofcirrhosis (1988) (0)
The duration of protection of school-age BCG vaccination in England (2017) (0)
Letter: Carbon monoxide and smoking. (1974) (0)
Distant disease. (1992) (0)
Reply to Hasford and to Spinola et al. (2020) (0)
Angiotensin receptor type 2 mediates hypersensitivity and hyperinnervation in an inflammatory pain model (2013) (0)
Beta‐adrenergic receptor blockers increase ventricular sympathetic innervation by directly enhancing sympathetic axonal sprouting (2009) (0)
Undergraduate Support Core Coordinator (2005) (0)
The early care of injuries of the genito-urinary tract. (1952) (0)
Letter: Incidence of childhood leukaemia. (1974) (0)
Letter: Smoking tables for carbon monoxide? (1973) (0)
Variant Creutzfeldt-Jakob disease: An epidemiological update in relation to geographically associated cases and history of vaccination (2003) (0)
Duration of protection of infant BCG vaccination in Ethnic minority groups in England (2015) (0)
Geographical distribution of sporadic Creutzfeldt-Jakob disease in the UK by sub-type: is it random? (2004) (0)
Why train the dental surgery assistant (1974) (0)
KU School of Medicine Mission-Based Allocation Model; Aligning Funding with Expectations (2018) (0)
Politics and entry into practice. (1984) (0)
Recent trends in the epidemiology of tuberculosis and leprosy. (1991) (0)
Chemical tests forphaeochromocytoma (1964) (0)
Bristol Cancer Help Centre (1990) (0)
Results from the second WHO external quality assessment for the molecular detection of respiratory syncytial virus, 2019–2020 (2023) (0)
Full title: CASE-CONTROL VACCINE EFFECTIVENESS STUDIES: PREPARATION, DESIGN, AND ENROLLMENT OF CASES AND CONTROLS (2017) (0)

This paper list is powered by the following services:

Other Resources About Peter G. Smith

www.lshtm.ac.uk

What Schools Are Affiliated With Peter G. Smith?

Peter G. Smith is affiliated with the following schools: